Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Enns

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Digestive Diseases and Sciences|December 8, 2011
Outcome of repeat ERCP after initial failed use of a needle knife for biliary accessF Donnellan, R Enns, E Kim, et al.
Gut|September 14, 2004
CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trialW J Sandborn, B G Feagan, G Radford-Smith, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|December 18, 2001
Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomicsB G Feagan, R Enns, R N Fedorak, et al.
Endoscopy|April 5, 2002
ERCP-related perforations: risk factors and managementR Enns, M A Eloubeidi, K Mergener, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 23, 2009
Add-on cases in the endoscopy unit: Factors that affect volumeB Segal, E Lam, J Amar, et al.
The American Journal of Gastroenterology|May 17, 2002
Clinical and histological predictors of response to medical therapy in collagenous colitisA Abdo, J Raboud, H J Freeman, et al.
Gut|February 10, 2009
Adalimumab for the treatment of fistulas in patients with Crohn's diseaseJ-F Colombel, D A Schwartz, W J Sandborn, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitisR Panaccione, R N Fedorak, G Aumais, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Digestive Diseases and Sciences|December 8, 2011
Outcome of repeat ERCP after initial failed use of a needle knife for biliary accessF Donnellan, R Enns, E Kim, et al.
Gut|September 14, 2004
CDP571, a humanised monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomised, double blind, placebo controlled trialW J Sandborn, B G Feagan, G Radford-Smith, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|December 18, 2001
Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomicsB G Feagan, R Enns, R N Fedorak, et al.
Endoscopy|April 5, 2002
ERCP-related perforations: risk factors and managementR Enns, M A Eloubeidi, K Mergener, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 23, 2009
Add-on cases in the endoscopy unit: Factors that affect volumeB Segal, E Lam, J Amar, et al.
The American Journal of Gastroenterology|May 17, 2002
Clinical and histological predictors of response to medical therapy in collagenous colitisA Abdo, J Raboud, H J Freeman, et al.
Gut|February 10, 2009
Adalimumab for the treatment of fistulas in patients with Crohn's diseaseJ-F Colombel, D A Schwartz, W J Sandborn, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|March 21, 2008
Review and clinical perspectives for the use of infliximab in ulcerative colitisR Panaccione, R N Fedorak, G Aumais, et al.
Pageof 4